Boston Scientific Extends EndoTex Purchase Option; NexStent Evaluated
This article was originally published in The Gray Sheet
Executive Summary
EndoTex Interventional Systems is planning an early 2004 launch of its self-expanding NexStent carotid stent outside the U.S., using Boston Scientific as exclusive distributor under an extended agreement between the firms